Skip to main content
Premium Trial:

Request an Annual Quote

Scripps Institute Joins GeneGo's Cardiac Pathways Group

NEW YORK (GenomeWeb News) – GeneGo said today that the Scripps Translational Science Institute has become the first member of a consortium that the company is building to develop a systems biology software and database platform for cardiovascular diseases. 
The company plans to add other members from the pharmaceutical and academic communities to the MetaMiner Cardiac Consortium. The members of the consortium will have a say in what cardiac-specific ontologies and pathway maps the company will incorporate into the MetaMiner product.
Scripps and any future consortium members, in return, will have free access to the product GeneGo develops. The company plans to put the product on the market six to 12 months after the consortium members have access to it, Julie Bryant, GeneGo’s VP of business development and marketing, told GenomeWeb Daily News today.
The company recently released a similar MetaMiner software and database platform for cystic fibrosis.
Cardiac Consortium memberships last for three years, and the company should be ready to release a MetaMiner Cardiac product within one to two years, Bryant said.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.